Detalles de la búsqueda
1.
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide.
J Neurooncol
; 166(2): 321-330, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38263486
2.
Anti-tumor and immune modulating activity of T cell induced tumor-targeting effectors (TITE).
Cancer Immunol Immunother
; 70(3): 633-656, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32865605
3.
IgA Fc-folate conjugate activates and recruits neutrophils to directly target triple-negative breast cancer cells.
Breast Cancer Res Treat
; 172(3): 551-560, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30155754
4.
Targeting CD138-/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity.
Biol Blood Marrow Transplant
; 22(5): 869-78, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26827660
5.
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells.
J Immunother Cancer
; 12(3)2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38519053
6.
Race-related Differences in Sipuleucel-T Response Among Men with Metastatic Castrate-Resistant Prostate Cancer.
Cancer Res Commun
; 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38856749
7.
CD20-targeted T cells after stem cell transplantation for high risk and refractory non-Hodgkin's lymphoma.
Biol Blood Marrow Transplant
; 19(6): 925-33, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23529012
8.
Microenvironment generated during EGFR targeted killing of pancreatic tumor cells by ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2 dependent pathway.
J Transl Med
; 11: 35, 2013 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-23394575
9.
Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 29(1): 122-133, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36255393
10.
Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells.
Res Sq
; 2023 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37986911
11.
A Th1 cytokine-enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells.
Cancer Immunol Immunother
; 61(4): 497-509, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21971587
12.
Activated T cells from umbilical cord blood armed with anti-CD3 × anti-CD20 bispecific antibody mediate specific cytotoxicity against CD20+ targets with minimal allogeneic reactivity: a strategy for providing antitumor effects after cord blood transplants.
Transfusion
; 52(1): 63-75, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21745212
13.
Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile.
Microbiol Spectr
; 10(1): e0256021, 2022 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35196802
14.
Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness.
Oncoimmunology
; 10(1): 1930883, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34123574
15.
Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells.
Front Immunol
; 12: 690437, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34290709
16.
Phase II clinical trial using anti-CD3 × anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) consolidation therapy for HER2 negative (0-2+) metastatic breast cancer.
J Immunother Cancer
; 9(6)2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34117114
17.
Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study.
J Cancer Res Clin Oncol
; 146(8): 2007-2016, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32449004
18.
Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients.
Oncoimmunology
; 9(1): 1773201, 2020 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32939319
19.
B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro.
J Neuroimmunol
; 309: 88-99, 2017 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28601295
20.
Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma.
J Control Release
; 229: 120-129, 2016 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27001893